Avantor, Inc. Increase (Decrease) in Accounts Receivable
Avantor, Inc. (AVTR) reported Increase (Decrease) in Accounts Receivable of $40.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-04-29
- Avantor, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $40.80M, a 5.56% decline year-over-year.
- Avantor, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$3.10M.
- Avantor, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$66.20M.
- Avantor, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $12.50M, a 362.96% increase year-over-year.
- Avantor, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$13.60M.
- Avantor, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$45.90M.
- Avantor, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$77.00M, a 270.35% decline from fiscal 2022.
- Avantor, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $45.20M, a 59.57% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-03-31 | $40.80M 10-Q · filed 2026-04-29 | $37.70M derived: sum of 2 quarters · filed 2026-04-29 | -$28.50M derived: sum of 3 quarters · filed 2026-04-29 | -$16.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$69.30M derived: sum of 2 quarters · filed 2026-02-11 | -$56.80M derived: sum of 3 quarters · filed 2026-02-11 | -$13.60M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$66.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$53.70M derived: sum of 2 quarters · filed 2025-10-29 | -$10.50M 10-Q · filed 2025-10-29 | -$22.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $55.70M 10-Q · filed 2025-08-01 | $44.00M derived: sum of 3 quarters · filed 2026-04-29 | $9.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $43.20M 10-Q · filed 2026-04-29 | $31.50M derived: sum of 2 quarters · filed 2026-04-29 | -$2.70M derived: sum of 3 quarters · filed 2026-04-29 | $0.00 derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$45.90M derived: sum of 2 quarters · filed 2026-02-11 | -$43.20M derived: sum of 3 quarters · filed 2026-02-11 | -$45.90M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$34.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$31.50M derived: sum of 2 quarters · filed 2025-10-29 | -$34.20M 10-Q · filed 2025-10-29 | -$56.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $0.00 10-Q · filed 2025-08-01 | -$21.90M derived: sum of 3 quarters · filed 2026-02-11 | -$69.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$2.70M 10-Q · filed 2025-04-25 | -$24.60M derived: sum of 2 quarters · filed 2026-02-11 | -$71.80M derived: sum of 3 quarters · filed 2026-02-11 | -$131.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$21.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$69.10M derived: sum of 2 quarters · filed 2026-02-11 | -$129.20M derived: sum of 3 quarters · filed 2026-02-11 | -$77.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$47.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | -$107.30M derived: sum of 2 quarters · filed 2024-10-25 | -$55.10M 10-Q · filed 2024-10-25 | -$108.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | -$60.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$7.90M 10-Q · filed 2024-07-26 | -$61.70M derived: sum of 3 quarters · filed 2025-02-07 | -$60.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $52.20M 10-Q · filed 2024-04-26 | -$1.60M derived: sum of 2 quarters · filed 2025-02-07 | -$800.00K derived: sum of 3 quarters · filed 2025-02-07 | -$39.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | -$53.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | -$53.00M derived: sum of 2 quarters · filed 2025-02-07 | -$92.10M derived: sum of 3 quarters · filed 2025-02-07 | $45.20M 10-K · filed 2025-02-07 |
| 2022-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$38.30M derived: sum of 2 quarters · filed 2023-10-27 | $99.00M 10-Q · filed 2023-10-27 | $144.30M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$39.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $98.20M 10-Q · filed 2023-07-28 | $143.50M derived: sum of 3 quarters · filed 2024-02-14 | $88.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $137.30M 10-Q · filed 2023-04-28 | $182.60M derived: sum of 2 quarters · filed 2024-02-14 | $127.10M derived: sum of 3 quarters · filed 2024-02-14 | $142.30M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $45.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$10.20M derived: sum of 2 quarters · filed 2024-02-14 | $5.00M derived: sum of 3 quarters · filed 2024-02-14 | $111.80M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$55.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$40.30M derived: sum of 2 quarters · filed 2022-10-28 | $66.50M 10-Q · filed 2022-10-28 | $118.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $122.00M 10-Q · filed 2022-07-29 | $173.80M derived: sum of 3 quarters · filed 2023-02-14 | $208.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $106.80M 10-Q · filed 2022-04-29 | $158.60M derived: sum of 2 quarters · filed 2023-02-14 | $193.10M derived: sum of 3 quarters · filed 2023-02-14 | $129.10M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $51.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $86.30M derived: sum of 2 quarters · filed 2023-02-14 | $22.30M derived: sum of 3 quarters · filed 2023-02-14 | $102.40M 10-K · filed 2023-02-14 |
| 2020-09-30 | $34.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$29.50M derived: sum of 2 quarters · filed 2021-10-29 | $50.60M 10-Q · filed 2021-10-29 | $42.60M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | -$64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $16.10M 10-Q · filed 2021-07-30 | $8.10M derived: sum of 3 quarters · filed 2022-02-11 | $11.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $80.10M 10-Q · filed 2021-04-28 | $72.10M derived: sum of 2 quarters · filed 2022-02-11 | $75.90M derived: sum of 3 quarters · filed 2022-02-11 | $94.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$4.20M derived: sum of 2 quarters · filed 2022-02-11 | $14.70M derived: sum of 3 quarters · filed 2022-02-11 | $68.90M 10-K · filed 2022-02-11 |
| 2019-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $22.70M derived: sum of 2 quarters · filed 2020-10-27 | $76.90M 10-Q · filed 2020-10-27 | $73.60M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $18.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $73.10M 10-Q · filed 2020-07-29 | $69.80M derived: sum of 3 quarters · filed 2021-02-16 | $122.60M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $54.20M 10-Q · filed 2020-04-29 | $50.90M derived: sum of 2 quarters · filed 2021-02-16 | $103.70M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $49.50M derived: sum of 2 quarters · filed 2021-02-16 | $83.40M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $52.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $86.70M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $33.90M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | -$14.10M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |